ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 16 for:    brain machine interface

Brain Machine Interface Control of an Robotic Exoskeleton in Training Upper Extremity Functions in Stroke

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01948739
Recruitment Status : Recruiting
First Posted : September 24, 2013
Last Update Posted : October 30, 2017
Sponsor:
Collaborators:
University of Houston
The Methodist Hospital System
National Institute of Neurological Disorders and Stroke (NINDS)
TIRR Memorial Hermann
Information provided by (Responsible Party):
Marcia k. O'Malley, William Marsh Rice University

Brief Summary:

The purpose of this study is:

  1. To augment the MAHI Exo-II, a physical human exoskeleton, with a non-invasive brain machine interface (BMI) to actively include patient in the control loop and thereby making the therapy 'active'.
  2. To determine appropriate robotic (kinematic data acquired through sensors on robotic device ) and electrophysiological ( electroencephalography- EEG based) measures of arm motor impairment and recovery after stroke.
  3. To demonstrate that the BMI controlled MAHI Exo-II robotic arm training is feasible and effective in improving arm motor functions in sub-acute and chronic stroke population.

Condition or disease Intervention/treatment Phase
Stroke Hemiparesis Device: MAHI EXO-II exoskeleton augmented with BMI system Not Applicable

Detailed Description:
This study aims to provide an adjunct to accelerate neurorehabilitation for stroke patients. The MAHI EXO-II, a physical human-robot interface, will be combined with a non-invasive brain-machine interface (BMI) to actively include the patient in the training of upper extremity motor functions.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: NRI:BMI Control of a Therapeutic Exoskeleton
Study Start Date : September 2013
Estimated Primary Completion Date : July 2018
Estimated Study Completion Date : July 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Rehabilitation

Arm Intervention/treatment
Experimental: BMI control of MAHI Exo-II
MAHI EXO-II exoskeleton augmented with BMI system will be used to actively include the patient in the control loop, thereby making the therapy 'active' and engaging patients with various impairment severity in rehabilitation tasks. Patients will receive longitudinal training with the BMI-robotic interface for 3-4 sessions per week, over a period of 3 months.
Device: MAHI EXO-II exoskeleton augmented with BMI system
In this longitudinal study, adult subjects with hemiparesis due to acute or chronic stroke will receive robotic-assisted training through an EEG-based BMI control of robotic exoskeleton to study the changes in upper extremity motor function, cortical plasticity (using the EEG and fMRI). The training will be provided 3x/week for 12 sessions over one-month period.
Other Names:
  • Brain Machine Interface System
  • Rehabilitation robotics




Primary Outcome Measures :
  1. Change from baseline in Fugl-Meyer Arm (FMA)Motor Score [ Time Frame: Baseline, 4 weeks, 6 weeks, 12 weeks ]
    FMA is a stroke-specific, performance based impairment index. It quantitatively measures impairment, based on Twitchell and Brunnstrom's concept of sequential stages of motor return in hemiplegic stroke patients. It uses an ordinal scale for scoring of 33 items for the upper limb component of the F-M scale; (0:can not perform; 1:can perform partially; 2:can perform fully). Total range is 0-66, 0 being poor and 66 normal.

  2. Change in cortical dynamics measured by Electroencephalography (EEG) [ Time Frame: Baseline, 4 weeks, 6 weeks, 12 weeks ]
    EEG activity in the low-frequency delta band will be used to train the neural interface for MAHI-EXO II. This outcome measure will quantify the change in brain activity occurring as a result of the training session with the neural interface and the robot. It is hypothesized that delta band power will increase (i.e., activity will become "stronger") and more synchronized with movement of the MAHI-EXO II, with training.

  3. Change from baseline in robotic motor coordination measure: trajectory error (TE) [ Time Frame: Baseline, 4 weeks, 6 weeks, 12 weeks ]
    Trajectory error measure is defined as a normalized difference between the desired and the participant's trajectory from one point in the workspace to another. Lower values reflect better performance.

  4. Change from baseline in robotic motor coordination measure: Smoothness of Movement (SM) [ Time Frame: Baseline, 4 weeks, 6 weeks, 12 weeks ]
    Smoothness of movement (SM) measure is a correlation coefficient that express the correlation between the participant's speed profile and a speed profile of an ideal trajectory utilizing the minimum jerk principle. It takes values between 0-1, where 1 optimal movement smoothness and 0 indicating poorest movement quality i.e., jerky movement.


Secondary Outcome Measures :
  1. Change from baseline in Jebsen-Taylor Hand Function Test (JTHFT) [ Time Frame: Baseline, 4 weeks, 6 weeks, 12 weeks ]
    The JTHFT is a motor performance test and measures the time needed to perform 7 everyday activities (e.g., writing, feeding). Lower times represent better performance.

  2. Change from baseline in Action Research Arm Test (ARAT) [ Time Frame: Baseline, 4 weeks, 6 weeks, 12 weeks ]
    The ARAT is used to assess subject's ability to manipulate-lift-release objects horizontally and vertically, which differs in size, weight and shape. The test consists of 19 items divided into 4 sub-tests (grasp, grip, pinch, gross arm movement) and each item is rated on a 4-point scale. The possible total score ranges between 0-57. Higher scores indicate better performance.

  3. Change in brain volume of activation and signal intensity using structural and functional magnetic resonance imaging [ Time Frame: Baseline, 4 weeks ]
    Changes in brain networks, both structural and functional activation patterns associated with movement before and after training with the neural interface and robot will be assessed in this outcome measure.

  4. Change from baseline in pain and fatigue [ Time Frame: Baseline, 4 weeks, 6 weeks, 12 weeks ]
    Pain and Fatigue will be measured on a visual analogue scale. After each training session as well as at baseline, post-treatment and on follow up assessment, participants will be asked to rate their current pain and fatigue on a scale ranging from 0 = none to 100 = worst possible.

  5. Change from baseline in grip and pinch strength [ Time Frame: Baseline, 4 weeks, 6 weeks, 12 weeks ]
    A grip dynamometer or pinch gauge will be used to measure maximum gross grasp force and pinch force, respectively.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Diagnosis of unilateral cortical and subcortical stroke confirmed by brain CT or MRI scan;
  2. Subacute or chronic stroke; interval of at least 3month and interval of at least 6 months from stroke to time of enrollment, respectively;
  3. No previous clinically defined stroke;
  4. Age between 18-75 years;
  5. Upper-extremity hemiparesis associated with stroke (manual muscle testing score of at least 2, but no more than 4/5 in the elbow and wrist flexors);
  6. No joint contracture or severe spasticity in the affected upper extremity: i.e., significant increase in muscle tone against passive ROM is no more than ½ of full range for given joint e.g., elbow, wrist and forearm movements.
  7. Sitting balance sufficient to participate with robotic activities;
  8. No neglect that would preclude participation in the therapy protocol;
  9. Upper limb proprioception present ( as tested by joint position sense of wrist);
  10. No history of neurolytic procedure to the affected limb in the past four months and no planned alteration in upper-extremity therapy or medication for muscle tone during the course of the study;
  11. No medical or surgical condition that will preclude participation in an occupational therapy program, that includes among others, strengthening, motor control and functional re-training of the upper limbs;
  12. No contraindication to MRI;
  13. No condition (e.g., severe arthritis, central pain) that would interfere with valid administration of the motor function tests;
  14. English-language comprehension and cognitive ability sufficient to give informed consent and to cooperate with the intervention.-

Exclusion Criteria:

  1. Orthopedic limitations of either upper extremity that would affect performance on the study;
  2. Untreated depression that may affect motivation to participate in the study;
  3. Subjects who cannot provide self-transportation to the study location.

Inclusion and Exclusion Criteria for Health Subjects:

Inclusion criteria:

  • able to understand and sign the consent form
  • age 18-65

Exclusion criteria: - Previous history of or MRI findings consistent with brain tumors, strokes, trauma or arterial venous malformations - Contraindication to MRI - Pregnancy


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01948739


Contacts
Contact: Marcia K. O'Malley, PhD (713) 348-3545 omalley@rice.edu
Contact: Gerard Francisco, MD (713) 797-5246 Gerard.E.Francisco@uth.tmc.edu

Locations
United States, Texas
The Institute for Rehabilitation and Research (TIRR) at Memorial Hermann Recruiting
Houston, Texas, United States, 77030
Contact: Nuray Yozbatiran, PhD    713-797-5282    Nuray.Yozbatiran@uth.tmc.edu   
Sponsors and Collaborators
The University of Texas Health Science Center, Houston
University of Houston
The Methodist Hospital System
National Institute of Neurological Disorders and Stroke (NINDS)
TIRR Memorial Hermann
Investigators
Principal Investigator: Marcia K. O'Malley, PhD William Marsh Rice University
Principal Investigator: Jose L. Contreras-Vidal, PhD University of Houston
Principal Investigator: Gerard Francisco, MD The University of Texas Health Science Center, Houston
Principal Investigator: Robert G. Grossman, MD The Methodist Hospital System

Additional Information:
Study Data/Documents: Study Protocol  This link exits the ClinicalTrials.gov site

Publications of Results:
Other Publications:
Responsible Party: Marcia k. O'Malley, Associate Professor of Mechanical Engineering, William Marsh Rice University
ClinicalTrials.gov Identifier: NCT01948739     History of Changes
Other Study ID Numbers: 1R01NS081854 ( U.S. NIH Grant/Contract )
1R01NS081854 ( U.S. NIH Grant/Contract )
First Posted: September 24, 2013    Key Record Dates
Last Update Posted: October 30, 2017
Last Verified: October 2017

Keywords provided by Marcia k. O'Malley, William Marsh Rice University:
Brain machine interface
Rehabilitation robotics
Stroke
Hemiparesis

Additional relevant MeSH terms:
Stroke
Paresis
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Neurologic Manifestations
Signs and Symptoms